Marshall Wace, LLP Singular Genomics Systems, Inc. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.86 - $6.44 $49,932 - $112,435	-17,459 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.94 - $12.09 $296,827 - $604,149	-49,971 Reduced 74.11%	17,459 $111,000
Q4 2021 Feb 14, 2022	SELL	$10.45 - $16.9 $4.23 Million - $6.84 Million	-404,540 Reduced 85.71%	67,430 $780,000
Q3 2021 Nov 15, 2021	SELL	$10.9 - $27.63 $298,267 - $756,067	-27,364 Reduced 5.48%	471,970 $5.28 Million
Q2 2021 Aug 25, 2021	BUY	$23.16 - $31.17 $11.6 Million - $15.6 Million	499,334 New	499,334 $13.7 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.4B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.